The HCMV portfolio includes letermovir (AIC246), an oral, late-stage antiviral candidate that is being investigated for the treatment and prevention of HCMV infection in transplant patients. Merck Research
As per the contract, Recipharm will conduct the formulation development work at the Recipharm Pharmaceutical Development site in Solna, near Stockholm. Astimex Pharma even has the chance to
Pursuant to the agreement, Pharmaron will offer discovery services in the areas of chemistry, drug metabolism and pharmacokinetics (DMPK), and efficacy screening to AstraZeneca. Financial details of the
The Specialized Programs of Research Excellence (SPORE) grant, spread over for a five-year period, is expected to identify new therapies to treat sarcoma. Sarcoma is a relatively rare
Led by Lutz Gissmann, the Division of Genome Modifications and Carcinogenesis set to begin assessing the therapeutic efficacy of the DKFZ’s HPV-specific plasmid DNA as part of the
Researchers of the firm have demonstrated the hLEC cells engraftment and bioactivity in vivo and their expandable capability. The newly issued ‘164 patent, which extends to 2022, has
The trial demonstrated that AUBAGIO could reduce the annualized relapse rate and prevent the progression of disability in patients with relapsing forms of multiple sclerosis (MS). The study
Abraxane phase II and phase III lung cancer trials lead investigator Mark Socinski said the FDA approval of Abraxane throws up more treatment options for all types of
Under the agreement, Epiomed will formulate the drug called intranasal scopolamine (INSCOP), which is effective when administered as a tablet or injected. Studies conducted with a precise dosage,
Make ME Vitamins, which include 1,000 mg of Vitamin C, is designed to provide the body with a balanced blend of nutrients, antioxidants and electrolytes. Premier Brands president
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.